Pulmonary Embolus
9
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.1%
1 terminated out of 9 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Emulation of the RECORD3 Trial Using Healthcare Claims Data
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
Enoxaparin Metabolism in Reconstructive Surgery Patients
Anticoagulation Length in Cancer Associated Thrombosis
Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism
Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients